igf 1 lr3 gh gut prevention Exploring the Therapeutic Potential of Targeting and IGF-1 in the Management of Obesity: Insights from the Interplay between These Hormones and Metabolism The GH/IGF-1 axis in ageing
Description
Ethical complexities arise in trial design, particularly concerning vulnerable groups like incarcerated individuals and people living with HIV, requiring stringent safeguards and specialized protocols (Riste et al., 2021)
The dosage is based on your medical condition and response to therapy
All patients provided informed consent
PMID: 8300824
